ArticleCells2019

Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis.

Sonia Simón Serrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.